Search

everythinglearnresearchcommunity

for

Search:↓

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

A SALT score of ≤ 20 indicates meaningful improvement in alopecia areata treatment.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

A new tool simplifies alopecia areata severity scoring but needs validation.

Low-dose oral minoxidil effectively promotes hair growth with minimal side effects.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Low-dose oral minoxidil is safe for the heart in the short term for hair loss patients.

Low-dose dutasteride effectively and safely promotes hair growth in men.

Aminexil clinical 5 effectively reduces hair loss and is well-tolerated.

KX-826 is safe and effectively increases hair count in men with hair loss.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

Significant hair regrowth doesn't always mean complete hair recovery in alopecia areata.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Low-dose oral minoxidil is safe for alopecia patients, even those prone to edema.

Androgenetic alopecia significantly harms quality of life, affecting emotions and relationships.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Telogen effluvium most affects quality of life in alopecia patients.

Androgenetic alopecia significantly affects women's emotions, especially older women.

Twice-weekly 5 mg dexamethasone can effectively treat extensive alopecia areata in many patients.

Both treatment combinations improved hair growth similarly and were safe.

Intralesional dutasteride improves hair growth in androgenic alopecia with minimal side effects.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Baricitinib significantly regrows hair in severe alopecia areata patients.